People · Operator
Named in public records as an officer, director or promoter · active 2020–2025 · Medical Devices, Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Momentis Surgical Ltd. | — | Medical Devices | Series C | $95.7M | $88.8M | 2020 |
| Potrero Medical, Inc. | — | Biotechnology | Series B | $76.2M | $9.9M | 2024 |
| MIVI Neuroscience, Inc. | — | Other Health Care | Series C | $67.4M | $4.3M | 2020 |
| Dermasensor, Inc. | — | Other Health Care | Series A | $29.2M | $37.5M | 2020 |
| Navigantis, Inc. | — | Other Health Care | Series A | $9.9M | $46.6M | 2024 |
Maurice Ferre at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Maurice Ferre on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Christopher Dewey | 3 | 4 |
| Carter Meyer | 1 | 14 |
| David Greenberg | 1 | 13 |
| Daniel Burnett | 1 | 11 |
| Frederic Moll | 1 | 10 |
| FRED MOLL | 1 | 8 |
| Frederic H. Moll | 1 | 8 |
| Robert Stern | 1 | 6 |
| Alan Chesler | 1 | 5 |
| Andrew ` Offer | 1 | 5 |
| David Matlin | 1 | 4 |
| Christopher Geyen | 1 | 3 |
| George Fazio | 1 | 3 |
| IVAN DELEVIC | 1 | 3 |
| Israel Frieder | 1 | 3 |
| James McCollum | 1 | 3 |
| Eyal Lifschitz | 1 | 3 |
| Taylor Whitman | 1 | 3 |
| Colby Wood | 1 | 2 |
| Michael Stansky | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.